(+)-UH 232 maleate
Cat. No. 0775
Chemical Name: cis-(+)-5-Methoxy-1-methyl-2-(di-N-
Biological ActivityD2 antagonist (Ki = 72.7 nM in a ligand binding assay; apparent KB = 14.5 nM in a cAMP accumulation assay); displays preferential activity at central dopamine autoreceptors. Stimulates a marked acceleration of dopamine synthesis and turnover. Produces locomotor stimulation. Exhibits little or no activity at central noradrenalin and 5-HT receptors. Also D3 partial agonist.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
on-line. Please contact Customer Service
References are publications that support the products' biological activity.
Hall and Strange (1997) Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors. Br. J. Pharmacol. 121 731. PMID: 9208141.
Griffon et al (1995) The preferential dopamine D3 receptor ligand, (+)-UH 232, is a partial agonist. Eur.J.Pharmacol. 282 R3. PMID: 7498261.
Svensson et al (1986) (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn Schmiedebergs Arch.Pharmacol. 334 234. PMID: 2880302.
Johansson et al (1985) Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. J.Med.Chem. 28 1049. PMID: 3927002.
If you know of a relevant reference for (+)-UH 232 maleate please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses (+)-UH 232 maleate from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: (+)-UH 232 maleate, supplier, D2-like, autoreceptor, antagonists, D3, partial, agonists, Dopamine, Non-Selective, Receptors, dopaminergic, (+)-UH232, maleate, Tocris Bioscience, D2 Receptor Antagonist products
Find multiple products by catalog number
New Products in this Area
G protein-biased D2 receptor partial agonist
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.